Medical experts answer questions about President Donald Trump's chronic venous insufficiency (CVI) diagnosis and what to know ...

The present paper described a rare and lethal adverse event following leech therapy. A 63-year-old man was referred to Nemazee Teaching Hospital (Shiraz, Iran) in December 2020 with a two-week history ...

IV infiltration and extravasation remind this cancer patient of the constant challenges of speaking up and advocating for ...

Intravenous thrombolysis remains a standard treatment for acute ischemic stroke within 4.5 hours after onset. Vascular reocclusion may occur after intravenous thrombolysis and may be preventable wi ...

Intravenous dexamethasone administered before surgery effectively reduces the incidence of rebound pain after resolution of the nerve block in patients undergoing wrist and hand procedures.

Gov. Abbott signs 'Jenifer's Law,' strengthening regulations in medical spa industry "Jenifer's Law" was inspired by Jenifer Cleveland, who died after IV therapy treatment at a Wortham medical spa.

HELSINKI, Finland—It may be possible to safely cut back on the level of monitoring performed in select patients with acute ischemic stroke treated with IV thrombolysis, results of the OPTIMISTmain ...

Isatuximab (Isa) subcutaneous (SC) via an on-body delivery system (OBDS) vs Isa intravenous (IV), plus pomalidomide and dexamethasone (Pd) in relapsed/refractory multiple myeloma (RRMM): Results of ...

HELSINKI, Finland—Adding IV tirofiban improves functional outcomes among patients undergoing systemic thrombolysis for acute ischemic stroke within 4.5 hours of symptom onset, results from the ...

More than a year after a former Dallas anesthesiologist was convicted of tampering with IV bags, survivors and their families say they are still waiting for the medical industry to take action ...

For patients with acute ischemic stroke due to large-vessel occlusion who present within 4.5 hours, intravenous tenecteplase before endovascular thrombectomy is associated with higher functional ...

A Bloomfield Hills-based company is planning to build facilities in Saudi Arabia and in Detroit to manufacture IV fluids.